HomeINDP • NASDAQ
Indaptus Therapeutics Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 4.57M | 15.96% |
Net income | -4.53M | -19.07% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -4.57M | -15.98% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.89M | -60.06% |
Total assets | 5.41M | -50.57% |
Total liabilities | 2.61M | 64.48% |
Total equity | 2.80M | — |
Shares outstanding | 16.03M | — |
Price to book | 2.00 | — |
Return on assets | -179.31% | — |
Return on capital | -331.91% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -4.53M | -19.07% |
Cash from operations | -5.05M | -28.21% |
Cash from investing | — | — |
Cash from financing | 3.15M | 897.13% |
Net change in cash | -1.90M | 47.64% |
Free cash flow | -3.61M | -27.01% |
Previous close
$0.34
Day range
$0.33 - $0.35
Year range
$0.31 - $2.76
Market cap
5.41M USD
Avg Volume
510.94K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2021
Website
Employees
7
